Clinical trials / NCT06757010
NCT06757010Phase 2Completed

A Study of NE3107 in Early Parkinson's

Study sponsor: BioVie Inc. · BIVI

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-05-01Actual
Enrollment · participants57Actual
Source updated2026-08-11Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Change from baseline in the MDS-UPDRS Part III

+ After

Measure: Monocyte Lymphocyte Ratio (MLR)

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

60 participants (planned)

+ After

57 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source

· 2 fields changed

Primary completion date changed

− Before

1 Dec 2025

+ After

1 May 2026

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source